NCT07468071
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07468071
Title Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments (KontRASt-R)
Acronym KontRASt-R
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA | FRA | ESP | DNK | CAN | BEL

Facility Status City State Zip Country Details
Novartis Investigative Site Sint-Niklaas Oost Vlaanderen 9100 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Montreal Quebec H4A 3J1 Canada Details
Novartis Investigative Site Sherbrooke Quebec J1H 5N4 Canada Details
Novartis Investigative Site Guangzhou Guangdong 510080 China Details
Novartis Investigative Site Changsha Hunan 410013 China Details
Novartis Investigative Site Copenhagen 2100 Denmark Details
Novartis Investigative Site Bron 69677 France Details
Novartis Investigative Site Saint-Herblain 44805 France Details
Novartis Investigative Site Villejuif 94800 France Details
Novartis Investigative Site Milan MI 20133 Italy Details
Novartis Investigative Site Milan MI 20162 Italy Details
Novartis Investigative Site Roma RM 00128 Italy Details
Novartis Investigative Site Kashiwa Chiba 2778577 Japan Details
Novartis Investigative Site Koto Ku Tokyo 1358550 Japan Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Seoul 03080 South Korea Details
Novartis Investigative Site Pamplona Navarre 31008 Spain Details
Novartis Investigative Site Barcelona 08035 Spain Details
Novartis Investigative Site Madrid 28050 Spain Details
Novartis Investigative Site Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field